Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Jun 2025 for Spero Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Kathleen Tregoning: trading record in brief
Kathleen Tregoning is a declared insider at 2 companies; the most frequent names are Cerevel Therapeutics Holdings, Inc. and Spero Therapeutics, Inc. The record holds 8 filings, for trades running from 15 September 2022 to 12 June 2025.
No open-market purchase appears, only 1 sale worth €237k. Outside the open market, there are 4 share grants and 2 option exercises.
The latest filing, published on 16 June 2025, reports a share grant in Spero Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kathleen Tregoning
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
20,000 shares0Common StockSEC:0000950170-25-087008:0
10,666 sharesCommon StockSEC:0000950170-24-090822:0
20,000 shares0Common StockSEC:0000950170-24-066624:0
3,150 shares@ US$10.05100.0% of flowCommon StockSEC:0000950170-23-073592:0
13,804 sharesCommon StockSEC:0000950170-23-072363:0
20,000 shares0Common StockSEC:0000950170-23-052703:0
15,000 shares0Common StockSEC:0000899243-22-031497:0
7 of 7 declarations
